Eye3 has gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.
$50,000 Awarded as 300 Members of the Innovation Community Celebrate HAMILTON, ON – September 29, 2022 – Boardball Inc. was named the grand prize winner
Original Press Release, Yahoo Finance, September 21, 2022 NORTH BRUNSWICK, N.J., Sept. 21, 2022 — Lactiga Therapeutics, an early-stage biotechnology company focused on improving the
Take a listen to our latest podcast as Rachel Bartholomew, CEO and Founder of Hyivy Health shares her medical device commercialization journey.
Hamilton, Ontario, a long-standing leader in health and life science research and innovation, was recently recognized with a 2021 investment of $6 million from the
Swati Matta, CEO & Founder of Koble, shares her startup journey and POV on the challenges of being a woman in the tech industry.
Understanding the common commercialization hurdles mentioned above is one thing, but having the funding and the time to navigate through them is another.
ORIGINAL PRESS RELEASE, Nicole Estrin, Innovative Health Diagnostics, August 16, 2022 Both laboratories join forces to expand access to an important and reliable endometriosis blood
ORIGINAL ARTICLE, Ritika Dubey, The Hamilton Spectator, July 26, 2022 Q and A: Dr. Harald Stover and Allarta co-founder Maria Antonakos talk about new cell-based therapy,
Medtech startup Cosm Medical has secured $4.7 million CAD to create custom medical devices for women suffering from pelvic floor disorders.
Hamilton, ON — On March 23, 2022, nearly 200 people from the region’s thriving life science ecosystem, gathered virtually for the culminating Showcase event for
ORIGINAL ARTICLE – Mohawk College, March 10, 2022 Is your tetanus shot still up to date? Are you confident all your records are available to
Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Learn how Swift Medical is reshaping the way wounds are imaged for diagnosis with AI and data-driven technology.
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Southern Ontario Pharmaceutical & Health Innovation Ecosystem (SOPHIE) Program brings together Innovation Factory’s commercialization services with the Synapse Life Science Consortium’s strategic network to leverage access to Hamilton’s unique life sciences capabilities and research expertise.
